株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

日本の開発業務受託機関 (CRO) 市場

Japan Contract Research Organization Market

発行 Frost & Sullivan 商品コード 337350
出版日 ページ情報 英文 72 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
日本の開発業務受託機関 (CRO) 市場 Japan Contract Research Organization Market
出版日: 2015年08月07日 ページ情報: 英文 72 Pages
概要

当レポートでは、開発業務受託機関 (CRO) 市場について調査分析し、収益予測 (相別、治療タイプ別) のほか、主な課題、アンメットニーズ、新興動向などについて、体系的な情報を提供しています。

エグゼクティブサマリー

市場概要

  • 製薬市場の概要
  • 市場の見通し

臨床試験市場の概要

  • 臨床試験市場の概要
  • 臨床試験シナリオ
  • 臨床試験のプロファイル
  • CRO市場区分:臨床開発段階別

予測と動向:総合市場

  • 予測の前提条件
  • 評価
  • 収益予測
  • 第I相・第II相セグメント:収益予測
  • 第III相・第IV相セグメント:収益予測
  • 前臨床セグメント:収益予測
  • データ管理セグメント:収益予測
  • 生物統計セグメント:収益予測
  • 中央臨床検査サービスセグメント:収益予測
  • ファーマコビジランス (医薬品安全性管理) セグメント:収益予測
  • 生物学的分析セグメント:収益予測
  • HEORセグメント:収益予測
  • CRO市場:主要動向

規制環境

  • 臨床研究規制概要
  • 臨床研究規制プロセス

競合環境

  • 競合構造
  • 競合分析:主要企業

まとめ

付録

Frost & Sullivanについて

目次
Product Code: 9AB9-00-34-00-00

Aging Population and Liberal Regulations will Propel Clinical Trial Growth

This research service presents an overview and analysis of the contract research organization (CRO) market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The study discusses the key challenges, unmet needs, and emerging trends in the market and. It covers the complete life cycle of the CRO industry, starting from preclinical trials to post-marketing surveillance. It provides detailed information on support services such as central laboratory services, bioanalytics, and data management.

Table of Contents

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. CRO Market Size by Stage of Clinical Development
  • 4. Market Size Estimation Methodology
  • 5. Scope and Segmentation
  • 6. Key Questions this Study will Answer
  • 7. Total CRO Market Engineering Measurements
  • 8. CEO's Perspective
  • 9. Key Companies to Watch
  • 10. Key Companies to Watch (continued)

Market Overview

  • 1. Pharmaceutical Market Overview
  • 2. Pharmaceutical Market Overview (continued)
  • 3. Market Perspective

Clinical Trials Market Overview

  • 1. Clinical Trials Market Overview
  • 2. Clinical Trials Market Overview (continued)
  • 3. Clinical Trials Scenario
  • 4. Profiles of Clinical Trials
  • 5. CRO Market Segmentation by Stage of Clinical Development

Forecasts and Trends-Total CRO Market

  • 1. Forecast Assumptions
  • 2. Measurements
  • 3. Revenue Forecast
  • 4. Revenue Forecast Discussion
  • 5. Phase I and Phase II Segments-Revenue Forecast
  • 6. Phase III and Phase IV Segments-Revenue Forecast
  • 7. Preclinical Segment-Revenue Forecast
  • 8. Preclinical Segment Revenue Forecast Discussion
  • 9. Data Management Segment-Revenue Forecast
  • 10. Data Management Segment Revenue Forecast Discussion
  • 11. Biostatistics Segment-Revenue Forecast
  • 12. Biostatistics Segment Revenue Forecast Discussion
  • 13. Central Laboratory Services Segment-Revenue Forecast
  • 14. Central Laboratory Services Segment Revenue Forecast Discussion
  • 15. Pharmacovigilance Segment-Revenue Forecast
  • 16. Pharmacovigilance Segment Revenue Forecast Discussion
  • 17. Bioanalytics Segment-Revenue Forecast
  • 18. Bioanalytics Segment Revenue Forecast Discussion
  • 19. HEOR Segment-Revenue Forecast
  • 20. HEOR Segment Revenue Forecast Discussion
  • 21. CRO Market-Key Trends

Regulatory Environment

  • 1. Clinical Research Regulatory Overview
  • 2. Clinical Research Regulatory Overview (continued)
  • 3. Clinical Research Regulatory Process

Competitive Environment

  • 1. Competitive Structure
  • 2. Competitive Analysis-Selected Key Market Participants
  • 3. Competitive Analysis-Selected Key Market Participants (continued)
  • 4. Competitive Analysis-Selected Key Market Participants (continued)
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)

The Last Word

  • 1. The Last Word-Discussion
  • 2. Legal Disclaimer

Appendix

  • 1. List of Exhibits
  • 2. List of Exhibits (continued)

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top